Vaccine development throughout the COVID-19 pandemic

As the COVID-19 pandemic continues to place world health and economies at risk, the field of vaccine development has seen an unprecedented push for innovation and collaborative efforts. With vaccines, such as the Pfizer–BioNTech (NY, USA and Mainz, Germany respectively), Moderna (MA, USA) and Oxford–AstraZeneca (Oxford, UK and Cambridge, UK) developed, tested and approved within the span of a few months, this rapid development has allowed for a growing discussion about the future of vaccine development, not only in response to ongoing pandemics but for the prevention of future global health crises.   In this journal article roundup, we take a look at articles published in our sister journal Bioanalysis and trace the journey of vaccine development to the present day. From...